Business BillionToOne targets over $2 billion valuation in US IPO October 18, 2025 12:06 am Reuters 0 Min Read SHARE Molecular diagnostics firm BillionToOne said on Friday it was aiming at a valuation of up to $2.42 billion in its U.S. initial public offering. This post was originally published on this site Previous Article U.S. tariffs push South Africa to revive ties with Türkiye after 12 years Next Article Alleged Antifa members indicted on terrorism-related charges, attempted murder
